Dr. Farlow cofounded and is the CTO of Serotiny. Serotiny designs custom multi-domain proteins for use in cell therapies. Justin received his doctorate from the UCSF in 2014. He worked in Zev Gartner’s lab to study the biophysics of Notch receptors in live cells. More generally, his work aimed to investigate the communication between different cell types in topologically-defined cellular microenvironments.
At Serotiny, Justin built a digital infrastructure to manage, design, and predict the functionality of synthetic proteins constructed from multiple protein domains. In the context of a cell therapy, such synthetic proteins include Chimeric Antigen Receptors, SynNotch, and Cas-based gene editing systems. Serotiny uses that inventive capability to translate clients’ plain-language requirements for novel functionality into novel proteins.